---
title: "AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Forecasts Amid Outlook Downgrades, Competitive Pressures"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275853943.md"
description: "AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Forecasts Amid Outlook Downgrades, Competitive Pressures"
datetime: "2026-02-13T05:37:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275853943.md)
  - [en](https://longbridge.com/en/news/275853943.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275853943.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275853943.md) | [繁體中文](https://longbridge.com/zh-HK/news/275853943.md)


# AlphaValue/Baader Europe Cuts Novo Nordisk Price Target, Forecasts Amid Outlook Downgrades, Competitive Pressures



### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market?](https://longbridge.com/en/news/278180989.md)
- [Novo Nordisk Finally Catches Bid After FDA Warns Telehealth Companies](https://longbridge.com/en/news/277805363.md)
- [Morgan Stanley Upgrades Novo Nordisk to Equal Weight (from Underweight), Sets Price Target at 250 Danish Kroner - BN](https://longbridge.com/en/news/277565823.md)
- [Ted Buchan & Co Purchases New Stake in Novo Nordisk A/S $NVO](https://longbridge.com/en/news/277357947.md)
- [US FDA warns Novo for second time about misleading Ozempic advertising](https://longbridge.com/en/news/277685391.md)